Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis. - Wikidata - wikimedia - TriplyDB

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q37026577

about

New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.Antiinfectives targeting enzymes and the proton motive force.Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture Nitazoxanide is active against Mycobacterium leprae.Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity.Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis

P2860

Q30371980-A15FE0D1-1069-4844-AC85-34E48306F254 Q30408277-41258E7C-5E4E-4600-BED6-936319A74A0A Q33810290-2E3072B0-62A0-4559-ACF0-175C2F68386B Q36419761-13E8AE3B-4ADB-40E7-AB8F-466BBD480EB5 Q36893907-3E7E4F5C-3859-40B0-B478-E0E91C6E2F18 Q38603774-8340EFD4-78FD-4984-A237-F58BA9BCFB48 Q40838217-133E2316-FB0E-416E-A51A-B188D91C7CBF Q43245570-121EB77B-DDA1-4CC3-A7E6-98AA4F803280 Q47235181-FF062373-92CD-4285-AB01-E9D201A5B1CD Q50780166-A3D24141-C898-4DBA-A842-DF36851DE61F Q57656314-CC8E81FF-B833-48D8-9939-6596A890DA9C

P2860

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q37026577

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@en

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@nl

type

label

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@en

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@nl

prefLabel

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@en

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@nl

P1433

Q37026577-DB645FD8-73D6-4A8D-A26B-E2DB56C4223E

P1476

Q37026577-B05B26BE-90B7-4A33-97A3-E839104C6201

P2093

Q37026577-0D100300-84E0-4CB4-9DEF-DADF91E8C2C9

Q37026577-49848320-A38C-4D43-96E4-620F178633E2

Q37026577-E6226513-2601-4D8D-A3CF-71D6A5B7F931

Q37026577-F65F2527-8FBE-46E9-800E-C42072BA5CBB

P2860

Q37026577-0E6A9383-FE9A-4AF2-AC2F-EE3D6914BFC1

Q37026577-11D58F7A-3BAE-444E-9E1E-073D8C1DFEDF

Q37026577-18425B10-DBE4-473E-9B4F-6BB11920D352

Q37026577-1E2668E7-44AA-4AB7-9F79-0B13000BBB46

Q37026577-207A9900-B813-4643-851E-AC8C6EDDDC55

Q37026577-242A11B5-79AC-4FF4-85EF-B9AAFE43E4A3

Q37026577-2FBA79EE-71EC-46B6-A235-29E9D715F433

Q37026577-37700272-93D0-4907-83F3-EE043F5AB106

Q37026577-3B14922F-5DAB-464F-B051-E43620EB864B

Q37026577-48DFAFBA-0825-4D0B-B05C-C8A17D74EC60

P304

Q37026577-978AF600-9E1E-4508-843E-33F368BF243C

P31

Q37026577-2ABCC720-D2F3-4653-AD5E-110760A5E356

P356

Q37026577-F1200599-A732-4D51-B884-7D47E9C0AD86

P407

Q37026577-095FF14B-817A-4646-BAE5-5F34509E1106

P433

Q37026577-E52B2F96-B609-4ABB-9BFA-3BB3A55E6F87

P478

Q37026577-90076CE6-E8C1-40E2-8733-CEEC28C07998

P50

Q37026577-0AD6577F-99DA-4E98-80E3-00D0C1F37E8F

Q37026577-A792A4A0-8C17-4CAB-A5CB-1476CB87BC89

Q37026577-BDA70533-EE03-452C-8AF5-57A5F021E4CC

P577

Q37026577-EC5801D0-1BD0-44D7-A85C-9343253D6BE1

P698

Q37026577-2F7512E1-82CF-4513-9DD1-C8E8EC278957

P921

Q37026577-8E35EB8E-78AE-42E8-A648-F78780A9F2CB

P932

Q37026577-BC467215-5293-45CC-B757-64561A514B70

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

@en

P2093

Carl F Nathan

http://www.w3.org/2001/XMLSchema#string

Kristina Shigyo

http://www.w3.org/2001/XMLSchema#string

Warren D Johnson

http://www.w3.org/2001/XMLSchema#string

Yves Mary Merveille

http://www.w3.org/2001/XMLSchema#string

P2860

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication

Global incidence of multidrug-resistant tuberculosis

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.

P304

2834-2837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02542-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Jean William Pape

Daniel W Fitzgerald

Oksana Ocheretina

P577

2013-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23507275

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

3716123

http://www.w3.org/2001/XMLSchema#string